PepGen (PEPG) Accumulated Depreciation (2021 - 2026)
PepGen (PEPG) reported Accumulated Depreciation of $4.2 million for Q1 2026, up 23.4% on a YoY basis from $3.4 million in Q1 2025, and up 8.13% sequentially from $3.9 million in Q4 2025.
PepGen (PEPG) Accumulated Depreciation (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Accumulated Depreciation data on file, last reported at $4.2 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation rose 23.4% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 23.4% YoY), and the FY2025 full-year result was $3.9 million, up 28.4% from the prior year.
- Accumulated Depreciation improved to $4.2 million in Q1 2026, from $3.9 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $4.2 million in Q1 2026 to a low of $245000.0 in Q3 2022.
- A 5-year average of $2.0 million and a median of $1.9 million in 2024 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation slipped 9.53% in 2022 and surged 397.96% in 2023, its largest moves.
- Tracing PEPG's Accumulated Depreciation over 5 years: stood at $389000.0 in 2022, then surged by 304.11% to $1.6 million in 2023, then surged by 93.77% to $3.0 million in 2024, then rose by 28.4% to $3.9 million in 2025, then gained by 8.13% to $4.2 million in 2026.
- Business Quant data shows PEPG's Accumulated Depreciation at $4.2 million in Q1 2026, $3.9 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 3.91 Mn |
| Sep 30, 2025 | 3.58 Mn |
| Jun 30, 2025 | 3.24 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 871,000.00 |
| Mar 31, 2023 | 540,000.00 |
| Dec 31, 2022 | 389,000.00 |
| Sep 30, 2022 | 245,000.00 |
| Jun 30, 2022 | 415,000.00 |
| Mar 31, 2022 | 471,000.00 |
| Dec 31, 2021 | 430,000.00 |